Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ IARS Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA544246
Description
Peptide sequence: SKHKPKFTFY DGPPFATGLP HYGHILAGTI KDIVTRYAHQ SGFHVDRRFG Sequence homology: Cow: 93%; Dog: 100%; Guinea Pig: 93%; Horse: 86%; Human: 100%; Mouse: 86%; Pig: 100%; Rabbit: 93%; Rat: 86%; Yeast: 100%; Zebrafish: 79%.
IARS is a member of aminoacyl-tRNA synthetases which catalyze the aminoacylation of tRNA by their cognate amino acid. Because of their central role in linking amino acids with nucleotide triplets contained in tRNAS, aminoacyl-tRNA synthetases are thought to be among the first proteins that appeared in evolution. Isoleucine-tRNA synthetase belongs to the class-I aminoacyl-tRNA synthetase family and has been identified as a target of autoantibodies in the autoimmune disease polymyositis/dermatomyositis. Two alternatively spliced variants have been isolated that represent alternate 5' UTRs.
Specifications
IARS | |
Polyclonal | |
Unconjugated | |
IARS1 | |
2510016L12Rik; AI327140; AU044614; E430001P04Rik; fi46h05; FLJ20736; IARS; IARS1; Iarsl; ILERS; ILRS; IRS; isoleucine tRNA ligase 1, cytoplasmic; isoleucine tRNA synthetase; isoleucine--tRNA ligase, cytoplasmic; isoleucine-tRNA synthetase; isoleucyl tRNA synthetase; isoleucyl-tRNA synthetase; isoleucyl-tRNA synthetase 1; isoleucyl-tRNA synthetase, cytoplasmic; PRO0785; wu:fi46h05; zgc:63790 | |
Rabbit | |
Affinity chromatography | |
RUO | |
3376 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Western Blot | |
0.5 mg/mL | |
PBS with 2% sucrose and 0.09% sodium azide | |
P41252 | |
IARS1 | |
Synthetic peptide directed towards the N-terminal of human IARS (aa 35-84). | |
100 μL | |
Primary | |
Human | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction